L3VLUP
ProSign in

BNTX · ARGX in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

BNTXARGX
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • BNTX
  • ARGX
0102030202120222023202420252026
Holders and value by quarter
QuarterBNTXARGX
Q3 20204 holders, $504m8 holders, $3.6bn
Q4 20203 holders, $142m7 holders, $4.1bn
Q1 20214 holders, $993m8 holders, $4.1bn
Q2 202110 holders, $3.9bn9 holders, $4.6bn
Q3 202112 holders, $4.2bn8 holders, $4.5bn
Q4 20219 holders, $3.1bn9 holders, $5.3bn
Q1 202210 holders, $1.9bn8 holders, $5.3bn
Q2 202211 holders, $1.8bn13 holders, $6.5bn
Q3 20228 holders, $1.8bn14 holders, $5.3bn
Q4 202213 holders, $2.3bn13 holders, $5.5bn
Q1 20238 holders, $1.6bn13 holders, $5.9bn
Q2 202310 holders, $1.2bn18 holders, $6.6bn
Q3 20239 holders, $1.2bn21 holders, $8.7bn
Q4 20239 holders, $1.1bn17 holders, $6.3bn
Q1 20247 holders, $975m13 holders, $6.8bn
Q2 20249 holders, $877m14 holders, $7.9bn
Q3 202410 holders, $2.0bn13 holders, $10.7bn
Q4 20248 holders, $2.0bn14 holders, $12.3bn
Q1 20259 holders, $1.6bn17 holders, $11.8bn
Q2 20256 holders, $1.9bn18 holders, $10.8bn
Q3 20254 holders, $1.7bn16 holders, $13.8bn
Q4 20258 holders, $1.2bn16 holders, $14.8bn
Q1 20266 holders, $528m11 holders, $12.3bn
Q2 20269 holders, $1.3bn14 holders, $15.0bn
BNTX

Biontech Se

Holders
9
Reported value
$1.1bn
Buyers
5
Sellers
2

Breadth +3 among 93 comparable managers.

Pharmaceuticals and biotechnologyBiological productsHealthcare: biopharma and medtech · L3VLUP
ARGX

Argenx Se

Holders
17
Reported value
$6.3bn
Buyers
12
Sellers
6

Breadth +6 among 93 comparable managers.

Pharmaceuticals and biotechnologyBiological productsHealthcare: biopharma and medtech · L3VLUP

Who holds both, Q4 2023

Among the 22 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only BNTX (5)

Acadian Asset Management LLC, Baillie Gifford & Co, Farallon Capital Management LLC, Squarepoint Ops LLC, Voloridge Investment Management LLC

Only ARGX (13)

Balyasny Asset Management LLC, D. E. Shaw & Co., Fidelity (FMR LLC), Holocene Advisors LP, Janus Henderson Group Ltd, Marshall Wace LLP, MFS Investment Management, Millennium Management LLC, Moore Capital Management LP, Point72 Asset Management LP, T. Rowe Price Associates Inc, Verition Fund Management LLC, Walleye Capital LLC

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →